多发性硬化症：诊断、管理及未来机遇
Multiple Sclerosis: Diagnosis, Management, and Future Opportunities.
作者信息
Maida Elisabetta, Lavorgna Luigi
机构信息
Department of Advanced Medical and Surgical Sciences, University of Campania Luigi Vanvitelli, 80131 Napoli, Italy.
出版信息
J Clin Med. 2023 Jul 8;12(14):4558. doi: 10.3390/jcm12144558.
Abstract
Multiple sclerosis (MS) is one of the most common inflammatory neurological diseases which leads to a highly heterogeneous set of symptoms and signs due to the differential involvement of the motor, sensory, visual, and autonomic systems [...].
摘要
多发性硬化症（MS）是最常见的炎症性神经疾病之一，由于运动、感觉、视觉和自主神经系统的不同程度受累，会导致一系列高度异质性的症状和体征[……]
相似文献
1
Multiple Sclerosis: Diagnosis, Management, and Future Opportunities.多发性硬化症：诊断、管理及未来机遇
J Clin Med. 2023 Jul 8;12(14):4558. doi: 10.3390/jcm12144558.
2
[Subclinical lesions of peripheral nervous system in multiple sclerosis patients].[多发性硬化症患者周围神经系统的亚临床病变]
Neurol Neurochir Pol. 2004 Jul-Aug;38(4):257-64.
3
The multiple sclerosis prodrome: Emerging evidence, challenges, and opportunities.多发性硬化前驱期：新出现的证据、挑战和机遇。
Mult Scler. 2021 Jan;27(1):6-12. doi: 10.1177/1352458520914844. Epub 2020 Mar 31.
4
Encephalomyelopathy associated with HTLV-I a primary disease or coexisting with multiple sclerosis?与人类嗜T淋巴细胞病毒I型相关的脑脊髓病：一种原发性疾病还是与多发性硬化症共存？
Dement Neuropsychol. 2013 Oct-Dec;7(4):439-443. doi: 10.1590/S1980-57642013DN74000014.
5
Temperature sensitivity in multiple sclerosis: An overview of its impact on sensory and cognitive symptoms.多发性硬化症中的温度敏感性：其对感觉和认知症状影响的概述
Temperature (Austin). 2018 Sep 5;5(3):208-223. doi: 10.1080/23328940.2018.1475831. eCollection 2018.
6
Rare onset symptoms in multiple sclerosis.多发性硬化症的罕见起病症状。
Acta Clin Belg. 2016 Jun;71(3):154-7. doi: 10.1080/17843286.2016.1147675. Epub 2016 Apr 21.
7
Common Clinical and Imaging Conditions Misdiagnosed as Multiple Sclerosis: A Current Approach to the Differential Diagnosis of Multiple Sclerosis.被误诊为多发性硬化症的常见临床和影像学病症：多发性硬化症鉴别诊断的当前方法
Neurol Clin. 2018 Feb;36(1):69-117. doi: 10.1016/j.ncl.2017.08.014.
8
Gastrointestinal dysfunction in neuroinflammatory diseases: Multiple sclerosis, neuromyelitis optica, acute autonomic ganglionopathy and related conditions.神经炎症性疾病中的胃肠道功能障碍：多发性硬化、视神经脊髓炎、急性自主神经节病变及相关疾病。
Auton Neurosci. 2021 May;232:102795. doi: 10.1016/j.autneu.2021.102795. Epub 2021 Mar 13.
9
Seropositive Neuromyelitis Optica in a Case of Undiagnosed Ankylosing Spondylitis: A Neuro-Rheumatological Conundrum.未确诊的强直性脊柱炎病例中的血清阳性视神经脊髓炎：一个神经风湿病学难题
Qatar Med J. 2022 Jul 7;2022(3):29. doi: 10.5339/qmj.2022.29. eCollection 2022.
10
Paroxysmal Symptoms in Multiple Sclerosis-A Review of the Literature.多发性硬化症的阵发性症状——文献综述
J Clin Med. 2020 Sep 25;9(10):3100. doi: 10.3390/jcm9103100.
引用本文的文献
1
Epstein-Barr Virus and Human Endogenous Retrovirus in Japanese Patients with Autoimmune Demyelinating Disorders.日本自身免疫性脱髓鞘疾病患者中的 Epstein-Barr 病毒和人类内源性逆转录病毒。
Int J Mol Sci. 2023 Dec 5;24(24):17151. doi: 10.3390/ijms242417151.
本文引用的文献
1
Health related quality of life in the domain of physical activity predicts confirmed disability progression in people with relapsing remitting multiple sclerosis.体力活动领域的健康相关生活质量可预测复发缓解型多发性硬化患者的确诊残疾进展。
Mult Scler Relat Disord. 2023 Jul;75:104731. doi: 10.1016/j.msard.2023.104731. Epub 2023 Apr 28.
2
Disease Reactivation in Secondary Progressive Multiple Sclerosis Patients Switching from Fingolimod to Siponimod: A Case Series.从芬戈莫德转换为西波尼莫德的继发进展型多发性硬化症患者的疾病再激活：病例系列
J Clin Med. 2022 Oct 13;11(20):6033. doi: 10.3390/jcm11206033.
3
Quality of Life Changes in Early-Onset Multiple Sclerosis: A 4-Year Follow-Up Study.早发性多发性硬化症患者生活质量的变化：一项4年随访研究
J Clin Med. 2022 Sep 4;11(17):5226. doi: 10.3390/jcm11175226.
4
Symptom-Level Disability Status Assessed with an Electronic Unsupervised Patient-Reported Expanded Disability Status Scale (ePR-EDSS) in Multiple Sclerosis Patients-The Example of Croatia.采用电子无监督患者报告扩展残疾状态量表（ePR-EDSS）评估多发性硬化症患者的症状水平残疾状况——以克罗地亚为例。
J Clin Med. 2022 Jul 14;11(14):4081. doi: 10.3390/jcm11144081.
5
Cutaneous Adverse Reactions Associated with Monoclonal Antibodies Treatment in Multiple Sclerosis: Case Reports and Short Literature Review.多发性硬化症中与单克隆抗体治疗相关的皮肤不良反应：病例报告及文献综述
J Clin Med. 2022 Jun 27;11(13):3702. doi: 10.3390/jcm11133702.
6
Effect of Rituximab Compared with Natalizumab and Fingolimod in Patients with Relapsing-Remitting Multiple Sclerosis: A Cohort Study.利妥昔单抗与那他珠单抗和芬戈莫德治疗复发缓解型多发性硬化症患者的疗效比较：一项队列研究
J Clin Med. 2022 Jun 22;11(13):3584. doi: 10.3390/jcm11133584.
7
PECAM-1 Is Down-Regulated in γδT Cells during Remission, but Up-Regulated in Relapse of Multiple Sclerosis.血小板内皮细胞黏附分子-1（PECAM-1）在缓解期的γδT细胞中表达下调，但在多发性硬化症复发期上调。
J Clin Med. 2022 Jun 4;11(11):3210. doi: 10.3390/jcm11113210.
8
Prognostic Markers of Ocrelizumab Effectiveness in Multiple Sclerosis: A Real World Observational Multicenter Study.奥瑞珠单抗治疗多发性硬化有效性的预后标志物：一项真实世界观察性多中心研究
J Clin Med. 2022 Apr 7;11(8):2081. doi: 10.3390/jcm11082081.
9
The Timing of Kinematic and Kinetic Parameters during Gait Cycle as a Marker of Early Gait Deterioration in Multiple Sclerosis Subjects with Mild Disability.步态周期中运动学和动力学参数的时机作为轻度残疾多发性硬化症患者早期步态恶化的标志物
J Clin Med. 2022 Mar 29;11(7):1892. doi: 10.3390/jcm11071892.
10
Reflex Locomotion Therapy for Balance, Gait, and Fatigue Rehabilitation in Subjects with Multiple Sclerosis.用于多发性硬化症患者平衡、步态和疲劳康复的反射性运动疗法
J Clin Med. 2022 Jan 23;11(3):567. doi: 10.3390/jcm11030567.
Zotero 插件